Things to Come

The next few years may see a number of changes to medicine, but Francis Collins, the director of the US National Institutes of Health, is most excited about the prospect of people being able to have their genomes sequenced at a reasonable cost to inform and tailor their medical care, as he tells USA Today's Brian Gallagher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Hoping for More

Making the Most

Billion More?

Put It in the Jar

Greener Pastures

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.